Posts in category Healthcare


Two Interesting Biotech Stocks with Upcoming Catalysts: Kamada Ltd. (KMDA), Dynavax Technologies (DVAX)

Kamada: Jefferies Sees 60% Upside for the Stock Kamada Ltd (NASDAQ:KMDA) has an upcoming PDUFA …

Read more

Synergy Pharmaceuticals Inc (SGYP) Trulance Market Adoption Pattern Looks Positive: Canaccord

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) stock is on the downward spiral today, to the harsh, discordant …

Read more

Genocea Biosciences Inc (GNCA) May Be Crashing, But Here’s Why Cowen Sees A Significantly Undervalued Stock

Genocea Biosciences Inc (NASDAQ:GNCA) shares were plummeting almost 15% yesterday after the biotech firm and …

Read more

Valeant Pharmaceuticals Intl Inc Faces Uncertain Future, Endo Not the Most Attractive Near-Term Stock

Valeant Still Has Higher Risk Profile Despite ‘Solid’ Q2 Results Valeant Pharmaceuticals Intl Inc (NYSE:VRX) …

Read more

Most Important Part of Novavax, Inc. (NVAX) 2Q Update May Point to NanoFlu, Wagers Cantor

Novavax, Inc. (NASDAQ:NVAX) shares were rising 5% in after-hours trading yesterday after the company reported …

Read more

Ocular Therapeutix Inc (OCUL) Gets A Bullish Vote Following 2Q:17 Update

Ocular Therapeutix Inc (NASDAQ:OCUL) shares are on a roughly 4% dip today after the biotech …

Read more

What You Need To Know About Galena Biopharma Inc (GALE) Merger With SELLAS; Maxim Shines Light

Yesterday, Galena Biopharma Inc (NASDAQ:GALE) and SELLAS Life Sciences announced they have entered into an …

Read more

ACADIA Pharmaceuticals Inc. (ACAD) Nuplazid on a Roll, Marvels Cowen

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares are shooting up almost 17% with investors clearly paying keen …

Read more

What Analysts Are Saying About Biotech Stocks Achillion Pharmaceuticals, Inc. And ACADIA Pharmaceuticals Inc.

Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares are rising about 25% in Wednesday’s trading …

Read more

This Top Analyst Says Avinger Inc (AVGR) Must Find a Buyer ASAP

Avinger Inc (NASDAQ:AVGR) released second-quarter earnings last evening that have left top analyst Jason Mills …

Read more